Skip to main content
GoodMoatv1.3
Sign in
GNLX logo

GNLX

CompareEarnings: May 31, 2026

Genelux Corp

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Genelux Corp

Did you know?

Capital expenditures increased by 188% from FY24 to FY25.

Current Price

$2.85

+4.01%
Profile
Valuation (TTM)
Market Cap$108.45M
P/E-3.37
EV—
P/B9.39
Shares Out38.05M
P/Sales—
Revenue$0.00
EV/EBITDA—

Genelux Corp (GNLX) Insider Trades

GNLX Insider Trading Activity

Track insider trading transactions for Genelux Corp (GNLX). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

Current stock price: $2.85. Market cap: $108.45M. This page displays the most recent insider transactions for GNLX, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Genelux Corp's investment outlook.